home / stock / mynd:cc / mynd:cc news

MYND:CC News and Press, Mynd Life Sciences Inc. From 04/12/23

Stock Information
Company Name: Mynd Life Sciences Inc.
Stock Symbol: MYND:CC
Market: CNQC
Website: myndsciences.com
Menu
MYND:CC MYND:CC Quote MYND:CC Short MYND:CC News MYND:CC Articles MYND:CC Message Board
Get MYND:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MYND:CC - MYND Life Sciences Inc. Provides Default Status Report

Vancouver, British Columbia--(Newsfile Corp. - April 12, 2023) - MYND Life Sciences  (CSE:  MYND ) (OTCQB:  MYNDF ) (" MYND " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological...
MYND:CC - MYND Life Sciences Inc. Announces Non-Binding MOU with German Based Oxygen Handel and Provides Default Status Report

Global expansion as MYND executes non-binding MOU with German based Oxygen Handel. Vancouver, British Columbia--(Newsfile Corp. - March 28, 2023) - MYND Life Sciences (CSE: MYND ) (OTCQB: MYNDF ) (" MYND " or the " Company "), a biopharmaceutical research and development company creating inn...

MYND:CC - MYND Life Sciences Inc. Granted Management Cease Trade Order

Vancouver, British Columbia--(Newsfile Corp. - March 1, 2023) - MYND Life Sciences Inc. (CSE: MYND) ("MYND" or the "Company") announces that it has been advised by its external auditors (the "Auditors") that they will not be in a position to complete their work on the Company's annual consolida...

MYND:CC - MYND Life Sciences Announces the Sale of Leasehold Tenant Improvements and Health Canada Cannabis License

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2023) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ( " MYND " or the " Company "), a biopharmaceutical research and development company creating innovated and precision medicines for patients with relentless neurological disea...
MYND:CC - MYND Life Sciences Announces Stock Option Grant

Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" Mynd " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentl...

MYND:CC - Mynd Life Sciences Terminates Proposed Transaction with Tidal Psychedelics

Vancouver, British Columbia--(Newsfile Corp. - June 29, 2022) - Mynd Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" Mynd " or the " Company ") announces that it has terminated the non-binding memorandum of understanding (" MOU ") to acquire all the issued and outstanding shares of Tid...

MYND:CC - MYND Life Sciences Announces Chief Scientific Officer, Dr. Wilf Jefferies, Induction as a National Academy of Inventors Fellow

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2022) - Mynd Life Sciences Inc.  (CSE: MYND) (OTCQB: MYNDF)   (" Mynd " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients wit...
MYND:CC - MYND Life Sciences Announces New Testing Methodologies for Measuring Cellular Responses to Microdosing with Psilocybins

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2022) - Mynd Life Sciences Inc.  (CSE: MYND) (OTCQB: MYNDF)   (" Mynd " or the " Company "), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with...

MYND:CC - MYND Life Sciences Announces $3.5 Million Share Offering

Vancouver, British Columbia--(Newsfile Corp. - April 21, 2022) - MYND Life Sciences Inc.  (CSE: MYND) (OTCQB: MYNDF)   (" MYND " or the " Company "), is pleased to announce that it plans to undertake a non-brokered private placement offering (the " Offering ") of common shares in sh...

MYND:CC - MYND Life Sciences Executes a Non-Binding MOU with Tidal Psychedelics

MYND expresses the intention to acquire all the issued and outstanding shares of Tidal Psychedelics Vancouver, British Columbia--(Newsfile Corp. - March 16, 2022) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) (" MYND " or the " Company "), a biopharmaceutical research and developme...
Previous 10 Next 10